NKTR
Nektar Therapeutics
59.20$
-1.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.73 | 26.13 | 17.78 | 29.60 | 99.38 | 9.82 | 12.84 | 8.34 | 7.38 | 7.11 | 7.18 | 3.27 | |
| 3.37 | 3.86 | 3.25 | 2.94 | 2.03 | 1.83 | 1.64 | 2.04 | 1.73 | 2.89 | 2.24 | 0.00 | |
| 20.36 | 22.27 | 14.53 | 26.66 | 97.34 | 7.99 | 11.21 | 6.30 | 5.64 | 4.22 | 4.94 | 3.27 | |
| 17.47 | 20.70 | 21.90 | 25.82 | 33.27 | 37.25 | 34.33 | 32.76 | 17.50 | 9.01 | 8.82 | 6.95 | |
| 4.84 | 4.90 | 4.76 | 5.04 | 6.78 | 8.46 | 8.79 | 10.05 | 7.40 | 6.11 | 5.60 | 4.07 | |
| 22.30 | 25.60 | 26.66 | 30.86 | 40.06 | 45.71 | 43.12 | 42.81 | 24.90 | 15.07 | 12.61 | 11.03 | |
| -1.95 | -3.33 | -12.13 | -5.74 | 57.29 | -37.72 | -31.91 | -36.51 | -19.26 | -10.85 | -7.67 | -7.75 | |
| 4.58 | 4.41 | 4.53 | 3.94 | 3.56 | 3.97 | 3.12 | 3.87 | 2.32 | 2.00 | 2.05 | 1.55 | |
| -6.43 | -9.14 | -16.40 | -9.24 | 56.86 | -37.72 | -37.29 | -42.82 | -29.26 | -21.81 | -8.69 | -9.73 | |
| -0.06 | 0.06 | 0.09 | 0.06 | 0.12 | 0.05 | 0.04 | 0.05 | 0.26 | -0.02 | -0.02 | -0.01 | |
| -6.37 | -9.19 | -16.50 | -9.30 | 56.74 | -37.77 | -37.33 | -42.87 | -29.51 | -21.79 | -8.68 | -9.73 | |
| -0.32 | -3.33 | -10.45 | -4.09 | 61.15 | -32.80 | -33.12 | -37.79 | -25.96 | -19.19 | -6.32 | -8.12 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.